Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain

Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain

Sigma receptors modulate nociception, offering a potential therapeutic target to treat pain, but relatively little is known regarding the role of sigma-2 receptors (S2R) in nociception. The purpose of this study was to investigate the in vivo analgesic and anti-allodynic activity and liabilities of...

Full description

Bibliographic Details
Main Authors: Lisa L. Wilson, Amy R. Alleyne, Shainnel O. Eans, Thomas J. Cirino, Heather M. Stacy, Marco Mottinelli, Sebastiano Intagliata, Christopher R. McCurdy, Jay P. McLaughlin
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Molecules
Subjects:
sigma
sigma-2 receptor
sigma-2 ligand
allodynia
analgesia
neuropathic pain
Online Access:https://www.mdpi.com/1420-3049/27/11/3617

Similar Items

Similar Items